Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy VolunteersCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52021-06-2415OAAI
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonistEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72021-01-0120PREAI
Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474BRITISH JOURNAL OF PHARMACOLOGYIF7.72020-02-128OAAI
Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targetsNATURE REVIEWS DRUG DISCOVERYIF101.82016-06-1756OAAI
Evaluating negative-symptom-like behavioural changes in developmental models of schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72014-05-0113PREAI
Effects of positive allosteric modulators (PAMs) of nicotinic receptors on intracellular Ca2+ concentration [Ca2+]i in mouse embryonic mesencephalic neurons in primary cultureBIOCHEMICAL PHARMACOLOGYIF5.62013-10-010PREAI
Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studiesJOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODSIF1.82011-07-0164PREAI
How Good Are Current Approaches to Nonclinical Evaluation of Abuse and Dependence?JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82011-03-0128PREAI
Behavioral Indices in Antipsychotic Drug DiscoveryJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82010-06-0188PREAI
Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouseEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72009-08-01123PREAI
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the ratEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72008-04-0114PREAI
Early behavioral screening for antidepressants and anxiolyticsDRUG DEVELOPMENT RESEARCHIF4.22006-01-0122PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向